Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Cancer Letters|October 26, 2013
One mouse, one patient paradigm: New avatars of personalized cancer therapyPrerna Malaney, Santo V Nicosia, Vrushank DavéCurrent Cancer Drug Targets|May 23, 2006
Vitamin D receptor is a novel drug target for ovarian cancer treatmentXiaohui Zhang, Santo V Nicosia, Wenlong BaiHuman Pathology|September 13, 2005
Significance of Fas receptor protein expression in epithelial ovarian cancerJennifer Reed, Ardeshir Hakam, Santo V Nicosia, et al.Pathology Oncology Research : POR|September 18, 2010
Expression of thyroid transcription factor-1 in malignant pleural effusionsAndras Khoor, Angela L Byrd-Gloster, Santo V NicosiaThe Journal of Biological Chemistry|October 16, 2004
Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomeraseFeng Jiang, Junying Bao, Pengfei Li, et al.The EMBO Journal|February 5, 2005
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylationYonghua Yang, Huayan Hou, Edward M Haller, et al.The Journal of Biological Chemistry|September 25, 2003
G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancerFeng Jiang, Pengfei Li, Albert J Fornace, et al.International Journal of Cancer|August 9, 2006
Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cellsHua Yang, Lili He, Patricia Kruk, et al.Hematology/Oncology Clinics of North America|September 10, 2003
Oncogenic pathways implicated in ovarian epithelial cancerSanto V Nicosia, Wenlong Bai, Jin Q Cheng, et al.The Journal of Biological Chemistry|April 13, 2004
p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligasePengfei Li, Chunrong Li, Xiuhua Zhao, et al.Pageof 7